» Articles » PMID: 27869758

The Impact of Rurality and Disadvantage on the Diagnostic Interval for Breast Cancer in a Large Population-Based Study of 3202 Women in Queensland, Australia

Overview
Publisher MDPI
Date 2016 Nov 22
PMID 27869758
Citations 10
Authors
Affiliations
Soon will be listed here.
Abstract

Delays in diagnosing breast cancer (BC) can lead to poorer outcomes. We investigated factors related to the diagnostic interval in a population-based cohort of 3202 women diagnosed with BC in Queensland, Australia. Interviews ascertained method of detection and dates of medical/procedural appointments, and clinical information was obtained from medical records. Time intervals were calculated from self-recognition of symptoms (symptom-detected) or mammogram (screen-detected) to diagnosis (diagnostic interval (DI)). The cohort included 1560 women with symptom-detected and 1642 with screen-detected BC. Symptom-detected women had higher odds of DI of >60 days if they were Indigenous (OR = 3.12, 95% CI = 1.40, 6.98); lived in outer regional (OR = 1.50, 95% CI = 1.09, 2.06) or remote locations (OR = 2.46, 95% CI = 1.39, 4.38); or presented with a "non-lump" symptom (OR = 1.84, 95% CI = 1.43, 2.36). For screen-detected BC, women who were Indigenous (OR = 2.36, 95% CI = 1.03, 5.80); lived in remote locations (OR = 2.35, 95% CI = 1.24, 4.44); or disadvantaged areas (OR = 1.69, 95% CI = 1.17, 2.43) and attended a public screening facility (OR = 2.10, 95% CI = 1.40, 3.17) had higher odds of DI > 30 days. Our study indicates a disadvantage in terms of DI for rural, disadvantaged and Indigenous women. Difficulties in accessing primary care and diagnostic services are evident. There is a need to identify and implement an efficient and effective model of care to minimize avoidable longer diagnostic intervals.

Citing Articles

Causes of Unwarranted Variation and Disparity in Breast Cancer Management in Regional and Rural Area.

Davis K, Campbell C, Costelloe R, Song T, Fylyk G, Yu P Breast J. 2025; 2024:9354395.

PMID: 39742374 PMC: 11208097. DOI: 10.1155/2024/9354395.


Individual and area level factors associated with the breast cancer diagnostic-treatment interval in Queensland, Australia.

Retell J, Cameron J, Aitken J, Youl P, Pyke C, Dunn J Breast Cancer Res Treat. 2023; 203(3):575-586.

PMID: 37930491 PMC: 10805972. DOI: 10.1007/s10549-023-07134-4.


Factors Associated with Diagnostic Delays among Tunisian Breast Cancer Patients.

Balhi S, Khiari H, Hsairi M Asian Pac J Cancer Prev. 2023; 24(2):471-477.

PMID: 36853295 PMC: 10162604. DOI: 10.31557/APJCP.2023.24.2.471.


Severity and risk factors of interval breast cancer in Queensland, Australia: a population-based study.

Kou K, Cameron J, Youl P, Pyke C, Chambers S, Dunn J Breast Cancer. 2023; 30(3):466-477.

PMID: 36809492 PMC: 10119209. DOI: 10.1007/s12282-023-01439-4.


Assurance of Timely Access to Breast Cancer Diagnosis and Treatment by a Regional Breast Health Clinic Serving Both Urban and Rural-Remote Communities.

Ewart E, Barton A, Chen L, Cuthbert R, Toplak K, Burrows A Curr Oncol. 2023; 30(1):1232-1242.

PMID: 36661744 PMC: 9858490. DOI: 10.3390/curroncol30010095.


References
1.
Li W, Lam W, Wong J, Chiu A, Chan M, Or A . Waiting to see the doctor: understanding appraisal and utilization components of consultation delay for new breast symptoms in Chinese women. Psychooncology. 2012; 21(12):1316-23. DOI: 10.1002/pon.2038. View

2.
Partridge A, Hughes M, Ottesen R, Wong Y, Edge S, Theriault R . The effect of age on delay in diagnosis and stage of breast cancer. Oncologist. 2012; 17(6):775-82. PMC: 3380876. DOI: 10.1634/theoncologist.2011-0469. View

3.
Redondo M, Rodrigo I, Pereda T, Funez R, Acebal M, Perea-Milla E . Prognostic implications of emergency admission and delays in patients with breast cancer. Support Care Cancer. 2008; 17(5):595-9. DOI: 10.1007/s00520-008-0513-2. View

4.
Montella M, Crispo A, Botti G, De Marco M, de Bellis G, Fabbrocini G . An assessment of delays in obtaining definitive breast cancer treatment in Southern Italy. Breast Cancer Res Treat. 2001; 66(3):209-15. DOI: 10.1023/a:1010622909643. View

5.
Crowley M, McCoy M, Bak S, Caron S, Ko N, Kachnic L . Challenges in the delivery of quality breast cancer care: initiation of adjuvant hormone therapy at an urban safety net hospital. J Oncol Pract. 2013; 10(2):e107-12. PMC: 3948707. DOI: 10.1200/JOP.2013.001164. View